Copyright
©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5524-5531
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5524
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5524
HBeAg-negative | HBeAg-positive | |||
Asian | Non-Asian | Asian | Non-Asian | |
n = 102 | n = 186 | n = 115 | n = 113 | |
Male | 71 (70) | 144 (77) | 60 (52)b | 84 (73) |
Age (yr, mean ± SD) | 44 ± 9.4 | 44 ± 10.9 | 34 ± 9.7 | 33 ± 11.9 |
BMI (kg/m2, mean ± SD) | 24.1 ± 3.1b | 26.4 ± 4.5 | 23.0 ± 3.5b | 25.1 ± 5.5 |
HBV DNA (log10 copies/mL, mean ± SD) | 6.5 ± 1.4a | 6.9 ± 1.3 | 8.4 ± 1.1b | 8.9 ± 1.0 |
Median ALT, U/L (Q1, Q3) | 73 (45, 115) | 103 (67, 140) | 90 (56, 144) | 118 (88, 196) |
Normal ALT1 | 17 (17)b | 12 (6.5) | 10 (9) | 5 (4) |
Weeks from baseline | HBeAg-negative | HBeAg-positive | ||
Asians | Non-Asian | Asians | Non-Asian | |
n = 102 | n = 186 | n = 115 | n = 113 | |
Week 4 | -2.9 ± 0.82 | -2.9 ± 0.80 | -3.1 ± 0.76 | -2.9 ± 0.77 |
Week 8 | -3.4 ± 1.04 | -3.5 ± 0.85 | -4.0 ± 1.07 | -3.8 ± 0.88 |
Asian | Non-Asian | |
Histology improvement1 | 95 (77.2) | 213 (71.5) |
Knodell necroinflammatory score | ||
Improvement | 99 (80.5) | 227 (76.2) |
No change | 9 (7.3) | 38 (12.8) |
Worsening | 2 (1.6) | 11 (3.7) |
Missing | 13 (10.6) | 22 (7.4) |
Knodell fibrosis score | ||
Improvement | 3 (2.4) | 15 (5.0) |
No change | 89 (72.4) | 227 (76.2) |
Worsening | 18 (14.6) | 33 (11.1) |
Missing | 13 (10.6) | 23 (7.7) |
- Citation: Pan CQ, Chan S, Trinh H, Yao A, Bae H, Lou L. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B. World J Gastroenterol 2015; 21(18): 5524-5531
- URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5524.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i18.5524